Results 141 to 150 of about 24,991 (171)

Fifty-three years' experience with randomized clinical trials of emergency portacaval shunt for bleeding esophageal varices in Cirrhosis: 1958-2011.

JAMA Surgery, 2014
IMPORTANCE Emergency treatment of bleeding esophageal varices (BEV) consists mainly of endoscopic and pharmacologic measures, with transjugular intrahepatic portal-systemic shunt (TIPS) performed when bleeding is not controlled.
M. Orloff
semanticscholar   +1 more source

Immediate and Long-Term Results of Portacaval Shunt Surgeries in Portal Hypertension: 10-Year Clinical Experience of a Regional Vascular Surgery Department

I P Pavlov Russian Medical Biological Herald
INTRODUCTION: The number of patients with liver cirrhosis (LC) makes 20–40 cases per 100 thousand populations and rises steadily. A five-year survival rate of patients with LC in the compensation stage is 50%–62%, in the decompensation stage — 11%–40 ...
Yuri V. Chervyakov, Alexander V. Borisov, I. N. Staroverov, S. Pamputis, D. Zavyalov, G. Baranov   +5 more
semanticscholar   +1 more source

Outcome of laparoscopic splenectomy with sandwich treatment including pericardial devascularization and limited portacaval shunt for portal hypertension due to liver cirrhosis.

Journal of laparoendoscopic & advanced surgical techniques. Part A, 2013
AIM To investigate the feasibility, effectiveness, and safety of a combination therapy of laparoscopic splenectomy (LS) with pericardial devascularization (PD) (laparoscopic Hassab's procedure) with or without limited portacaval shunt (LPS) for patients ...
Shaoyong Zhao, Tao Lv, G. Gong, Changsong Wang, Bin Huang, Wenhao Zhou   +5 more
semanticscholar   +1 more source

Experience with portacaval shunt for portal hypertension.

New England Journal of Medicine, 1961
SINCE the beginning of our experience with the surgical treatment of portal hypertension, we have believed that the operation of choice is portacaval shunt and that splenorenal shunts, because they are small and so frequently inadequate, should be ...
G. Wantz, M. A. Payne
semanticscholar   +1 more source

Therapeutic portacaval shunt. Preliminary data on controlled trial and morbid effects of acute hyaline necrosis.

Archives of Surgery, 1974
In our study of a controlled trial of therapeutic portacaval shunt, preliminary data suggest the superiority of surgical over medical treatment. Utilizing the Life-Table method of analysis, our data thus far indicate a 90% to 95% chance that five-year ...
W. Mikkelsen
semanticscholar   +1 more source

Favourable outcome of hepatic veno-occlusive disease in a renal transplant patient receiving azathioprine, treated by portacaval shunt. Report of a case and review of the literature.

Digestion, 1984
Veno-occlusive disease (VOD) developed in a 45-year-old white male 2 years after cadaveric kidney transplantation while receiving combined immunosuppressive therapy with prednisone and azathioprine.
T. Eisenhauer, H. Hartmann, K. Rumpf, U. Helmchen, F. Scheler, W. Creutzfeldt   +5 more
semanticscholar   +1 more source

Sequential metabolic characteristics following portacaval shunt in rats.

European surgical research. Europaische chirurgische Forschung. Recherches chirurgicales europeennes, 1986
A portacaval shunt (PCS) model is frequently employed to study phenomena inherent in portal-systemic shunting of splanchnic blood. In many species, a PCS induces hepatic insufficiency, accompanied by encephalopathy.
J. E. de Boer, R. Oostenbroek, J. V. van Dongen, M. Janssen, P. Soeters   +4 more
semanticscholar   +1 more source

[Ultrasonic inspection of the permeability of surgical portacaval shunts].

Presse medicale (Paris, France : 1983), 1985
Ultrasonography was used to evaluate the patency of portocaval shunts in 9 patients: 2 with spleno-renal anastomosis, 4 with portocaval truncular anastomosis, 2 with mesenteric-caval shunt and 1 with atypical shunt. The shunt count be demonstrated in 7 of these 9 patients.
M, Zerbib, P, Pinto, A, Bonnin, C, Garrigues, H, Al Dahdah, Y, Chapuis   +5 more
openaire   +1 more source

Decreased reticuloendothelial phagocytic capacity in cirrhotic and portacaval shunt rats.

European surgical research. Europaische chirurgische Forschung. Recherches chirurgicales europeennes, 1987
In cirrhosis, the phagocytic function of the reticuloendothelial system (RES) is decreased. In order to investigate the mechanisms of the hepatic reduced phagocytic activity present in cirrhosis, the hepatic and splenic uptake of 51Cr sheep red blood ...
M. Capron-Laudereau, J. Gugenheim, M. Gigou, S. Crougneau, D. Houssin, H. Bismuth   +5 more
semanticscholar   +1 more source

Clinical Investigation of the Portacaval Shunt: I. Study Design and Preliminary Survival Analysis

, 1965
THE ROLE of a portacaval shunt in the prevention of hemorrhage from esophagogastric varices and in the prolongation of life of patients with cirrhosis is unknown.
F. C. Jackson, E. Perrin, Angelo E. Degradi, Albert G. Smith, Ly Lee   +4 more
semanticscholar   +1 more source